Decentralized and Hybrid Trials | Thought Leadership | ICON plc

An article by Gretchen Goller and Kristin Kinlaw which outlines patient feedback from a recent survey regarding the use of decentralized and hybrid trials in the pharmaceutical industry.

Related Information

Site and Patient Solutions

Making the Move to Virtual Clinical Trials

Patient Centricity: Design for the Patient Experience

Symphony Clinical Research Acquisition Offers Customers Hybrid Trial Solutions and Site Support Services

Connect with us